In another study designed to test the efficacy of genetically modified cells from OI individuals, Chamberlain et al. isolated BMSCs from two OI patients and used an adeno-associated virus to insert a construct designed to inactive mutated COL1A1 alleles (Chamberlain et al. 2004). The gene discussed is COL1A1; the disease is osteogenesis imperfecta.